Triple Negative Locally Advanced Non-resectable Breast Cancer trials recruiting in Ohio

Fewer than 3 recruiting trials found.

All Triple Negative Locally Advanced Non-resectable Breast Cancer trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
  NCT06827613 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus